Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25950861 | 0.97 | TLR7 (0.71) | TLR7TLR8 | |
| SCHEMBL6097027 | 0.93 | TLR7 (0.74) | TLR7TLR8 | |
| SCHEMBL14592757 | 0.92 | TLR7 (0.73) | TLR7TLR8 | |
| SCHEMBL14451796 | 0.92 | TLR7 (0.73) | TLR7TLR8 | |
| SCHEMBL14451795 | 0.91 | TLR7 (0.71) | TLR7TLR8 | |
| SCHEMBL14592863 | 0.91 | TLR7 (0.72) | TLR7TLR8 | |
| SCHEMBL21743128 | 0.91 | TLR7 (0.71) | TLR7TLR8 | |
| SCHEMBL5774831 | 0.91 | TLR7 (0.71) | TLR7TLR8 | |
| SCHEMBL24863717 | 0.90 | TLR7 (0.71) | TLR7TLR8 | |
| SCHEMBL3867030 | 0.90 | TLR7 (0.79) | TLR7TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040132766-A1 | 1H-imidazo dimers | 3M INNOVATIVE PROPERTIES COMPANY | 2004-07-08 | — | — | US | claimed |
| EP-1542688-A2 | 1H-IMIDAZO DIMERS | 3M Innovative Properties Company (US) | 2005-06-22 | — | — | EP | disclosed |
| US-20040132766-A1 | 1H-imidazo dimers | 3M INNOVATIVE PROPERTIES COMPANY | 2004-07-08 | — | — | US | disclosed |
| WO-2004028539-A2 | 1H-IMIDAZO DIMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-04-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132766-A1 | 1H-imidazo dimers | IL2, EIF2AK2, IRF3 | TLR7 173/4885TLR8 176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.